SYN - Synthetic Biologics' (SYN) CEO Steven Shallcross on Q1 2021 Results - Earnings Call Transcript

Synthetic Biologics, Inc. (SYN) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ET Company Participants Vincent Perrone – Director-Corporate Communication Steven Shallcross – Chief Executive and Financial Officer Michael Kaleko – Senior Vice President-Research and Development Vince Wacher – Head-Product and Corporate Development Conference Call Participants Michael Okunewitch – Maxim Group Jim Molloy – Alliance Global Partners Presentation Operator Good afternoon, and welcome to Synthetic Biologics 2021 First Quarter Investor Conference Call. [Operator Instructions] Please note, today’s event is being recorded. At this time, I would like to turn the call over to Vincent Perrone, Director of Corporate Communication at Synthetic Biologics. Vincent, please go ahead. Vincent Perrone Thank you, Rocco, and good afternoon, everyone. Welcome to Synthetic Biologics 2021 first quarter investor conference call. Today, I’m joined remotely by Steven Shallcross, Chief Executive and Financial Officer; Dr. Michael Kaleko, Senior Vice President of Research and Development; and

For further details see:

Synthetic Biologics' (SYN) CEO Steven Shallcross on Q1 2021 Results - Earnings Call Transcript